↓ Skip to main content

Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases

Overview of attention for article published in Frontiers in Pharmacology, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
1 X user

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases
Published in
Frontiers in Pharmacology, September 2022
DOI 10.3389/fphar.2022.999404
Pubmed ID
Authors

Fangyu Yang, Jianjiang Xue, Guixue Wang, Qizhi Diao

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 9%
Researcher 4 6%
Student > Bachelor 4 6%
Student > Master 3 4%
Professor 2 3%
Other 7 10%
Unknown 42 62%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Chemistry 3 4%
Environmental Science 2 3%
Agricultural and Biological Sciences 1 1%
Other 3 4%
Unknown 48 71%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2022.
All research outputs
#15,778,526
of 23,435,471 outputs
Outputs from Frontiers in Pharmacology
#6,807
of 16,971 outputs
Outputs of similar age
#238,119
of 434,249 outputs
Outputs of similar age from Frontiers in Pharmacology
#481
of 1,502 outputs
Altmetric has tracked 23,435,471 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,971 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,249 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,502 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.